Cancer pain related to lung cancer
Conditions
Interventions
QH Needle Therapy group:QH Needle Therapy plus usual care
Sponsors
Guangdong Provincial Hospital of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. An imaging and pathological diagnosis of lung cancer and Estimated survival time > 3 months; 2. Aged 18–80 years, male or female; 3. Suffering from moderate or severe cancer pain (a worst pain score of at least 4 on the Brief Pain Inventory -Short Form in Chinese version) 4. Cognitive ability to provide responses during outcome measurement.
Exclusion criteria
Exclusion criteria: 1. Pain unrelated to cancer or cancer treatment. (medical/arthritic disease that could confound or interfere with evaluation of pain or efficacy); 2. Comorbidities such as serious heart, kidney, or liver disease; 3. Severe mental disorder or drug abuse; 4. Pregnant or breastfeeding women; 5. Contraindications to opioids, such as severe respiratory depression, raised intracranial pressure, paralytic ileus, acute abdomen, chronic obstructive airway disease, pulmonary heart disease, acute asthmatic attack, and hypercapnia; 6. Patients are allergic to opioids, non-steroidal anti-inflammatory drugs(NAIDs) , and alcohol; 7. Severe skin infection, lesions, ulcers, and soars in acupuncture area or severe coagulation disorders due to hepatic diseases, diabetes or other disease; 8. Diagnosed with refractory cancer pain and have indications of interventional therapy; 9. Recently received a palliative radiotherapy, nerve lesion, or interventional treatment; 10. Pain related to an oncologic emergency(Bone fracture or impending fracture of weight-bearing bone, neuroaxial metastases with threatened neural injury, infection, obstructed or perforated viscus).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain Relief Rates; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain measurement;Douleur Neuropathique 4 questions;PS(ECOG)score;EORTCQLQ-C30 (The European O-rganization for Reasearch and Treatment of Cancer Quality of Life Questionnare-Core 30);Breakthrough pain;Pain-free interval (time from treatment to pain relief [NRS<2]);Duration of pain relief;Analgesic consumption; | — |
Countries
China
Contacts
Public ContactWang Yingqi
Guangdong Provincial Hospital of Chinese Medicine
Outcome results
None listed